Regenex Pharmaceuticals (China)

Recent papers from Regenex Pharmaceuticals (China)

1. Regulatory Effect of Sea Rice Bio-Fermentation Product on the Melanin Synthesis PathwayFermentation · 2026
2. Multi-omics integration reveals macrophage polarization and ferroptosis as key mechanisms underlying kaempferol’s therapeutic efficacy in peripheral artery diseaseFrontiers in Immunology · 2026
3. Qianjin Baoyun Wan reduces spontaneous abortion and the prothrombotic state in pregnant ratsJournal of Traditional and Complementary Medicine · 2026
4. Cul4B up‐regulation attenuates sepsis‐induced acute lung injury by promoting NLRP3 ubiquitination and inhibiting NLRP3 inflammasome activationBritish Journal of Pharmacology · 2026
5. An antisense method for efficient exon skipping and its application to Duchenne muscular dystrophyProceedings of the National Academy of Sciences · 2026
6. Synthesis and Characterization of a Methoxypolyethylene Glycol-Modified Bortezomib ProdrugMacromol—A Journal of Macromolecular Research · 2026
7. Matrigel/serum-free, high-fidelity patient-derived tumor-like cell clusters as an in vitro platform for large-scale compound screening and chemoresistance prediction in oral cancerBMC Medicine · 2026
8. ROCK-2: An ongoing open-label, randomized, multicenter phase 2 study of rocbrutinib versus investigator's choice of therapy in patients with R/R non-GCB DLBCL.Journal of Clinical Oncology · 2026
9. An in situ generated CAR-M with IFN-γ and negative dominance Sirpα isoform augments hepatocellular carcinoma immunotherapyJournal of Nanobiotechnology · 2026
10. A Study on the efficiency of protein extraction from oxytetracycline residues using the method of electrochemical oxidationEnvironmental Technology · 2026
11. A flexible polypyrrole/GelMA self-supported electrode for supercapacitors by confined interfacial electrodepositionRSC Advances · 2026
12. The ErChen Decoction and Its Active Compounds Ameliorate Non-Alcoholic Fatty Liver Disease Through Activation of the AMPK Signaling PathwayPharmaceuticals · 2025
13. Innovative Safe Sunscreens Technology: Evaluation of Skin Penetration Through In Vitro/In Vivo Assays and Environmental FriendlinessJournal of Cosmetic Dermatology · 2025
14. HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety ProfilesMolecular Cancer Therapeutics · 2025
15. Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapyFrontiers in Pharmacology · 2025
16. SDP-LIV1, a Novel and Optimized LIV-1 Antibody-drug Conjugate Demonstrating Superior Anti-Tumor Efficacy and Favorable Safety Profile for Treatment of Solid TumorsMolecular Cancer Therapeutics · 2025
17. The evolving chemistry of cADPR analogues: from marine discovery to calcium signaling toolsBioorganic Chemistry · 2025
18. Removal of heavy metal ions in wastewater by using aluminum carbide (AlC) monolayerPhosphorus, sulfur, and silicon and the related elements · 2025
19. Pharmacokinetics, safety, and efficacy of mixed formulation of fosrolapitant and palonosetron (HR20013) in combination with dexamethasone in patients with solid tumors scheduled for highly emetogenic cisplatin-based chemotherapy: a phase I trialBMC Medicine · 2025
20. Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signallingBritish Journal of Pharmacology · 2025